» Articles » PMID: 21920268

Erectile Dysfunction and Risk of Cardiovascular Disease: Meta-analysis of Prospective Cohort Studies

Overview
Date 2011 Sep 17
PMID 21920268
Citations 152
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Our goal was to evaluate the association between erectile dysfunction (ED) and risk of cardiovascular disease (CVD) and all-cause mortality by conducting a meta-analysis of prospective cohort studies.

Background: Observational studies suggest an association between ED and the incidence of CVD. However, whether ED is an independent risk factor of CVD remains controversial.

Methods: The PubMed database was searched through January 2011 to identify studies that met pre-stated inclusion criteria. Reference lists of retrieved articles were also reviewed. Two authors independently extracted information on the designs of the studies, the characteristics of the study participants, exposure and outcome assessments, and control for potential confounding factors. Either a fixed- or a random-effects model was used to calculate the overall combined risk estimates.

Results: Twelve prospective cohort studies involving 36,744 participants were included in the meta-analysis. The overall combined relative risks for men with ED compared with the reference group were 1.48 (95% confidence interval [CI]: 1.25 to 1.74) for CVD, 1.46 (95% CI: 1.31 to 1.63) for coronary heart disease, 1.35 (95% CI: 1.19 to 1.54) for stroke, and 1.19 (95% CI: 1.05 to 1.34) for all-cause mortality. Sensitivity analysis restricted to studies with control for conventional cardiovascular risk factors yielded similar results. No evidence of publication bias was observed.

Conclusions: This meta-analysis of prospective cohort studies suggests that ED significantly increases the risk of CVD, coronary heart disease, stroke, and all-cause mortality, and the increase is probably independent of conventional cardiovascular risk factors.

Citing Articles

Association of total testosterone levels with cardiometabolic diseases in men with erectile dysfunction.

Chen B, Tsai P, Jiann B Sex Med. 2025; 12(6):qfae089.

PMID: 39801930 PMC: 11723798. DOI: 10.1093/sexmed/qfae089.


Inflammation as a Potential Mechanism Contributing to Sexual Functioning Following Initiation of Gender-Affirming Hormone Therapy.

Irvin M, Schutz D, Lorenz T Curr Sex Health Rep. 2024; 16(2):104-118.

PMID: 39583291 PMC: 11583339. DOI: 10.1007/s11930-024-00385-2.


Patients' perceptions of nocturnal erectile function assessment with the RigiScan®.

Trip E, Elzevier H, Pelger R, Beck J Int J Impot Res. 2024; .

PMID: 39572851 DOI: 10.1038/s41443-024-01001-6.


Association of relative fat mass with prevalence of erectile dysfunction in US men: an analysis of NHANES 2001-2004.

Feng X, Ji N, Zhang B, Xia W, Chen Y Int J Impot Res. 2024; .

PMID: 39567672 DOI: 10.1038/s41443-024-01003-4.


Age-Dependent Effects of Homocysteine on Erectile Dysfunction Risk Among U.S. Males: A NHANES Analysis.

Diao X, Zhang C, Wang Z Am J Mens Health. 2024; 18(5):15579883241278065.

PMID: 39378081 PMC: 11462577. DOI: 10.1177/15579883241278065.